PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Induction Chemotherapy10.1007/978-3-319-28773-7_232016333-342Systemic Induction Chemotherapy for Advanced-Stage Epithelial Ovarian CancerMaurie Markmanhttp://link.springer.com/content/pdf/10.1007/978-3-319-28773-7_23
Clinical Trials in Ovarian Cancer10.36019/9780813586496-004201946-1612. Advanced Stage Epithelial Ovarian Cancer: Adjuvant Chemotherapyhttps://www.degruyter.com/view/book/9780813586496/10.36019/9780813586496-004.xml, https://www.degruyter.com/document/doi/10.36019/9780813586496-004/xml, https://www.degruyter.com/document/doi/10.36019/9780813586496-004/pdf
European Journal of Cancer10.1016/0959-8049(95)00274-m199531111778-1780A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinomaG.B. Kristensen, M. Baekelandt, I.B. Vergote, C. Tropehttps://api.elsevier.com/content/article/PII:095980499500274M?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:095980499500274M?httpAccept=text/plain
Ovarian Cancer - From Pathogenesis to Treatment10.5772/intechopen.808902018Chemotherapy for Primary and Recurrent Epithelial Ovarian CancerNora Naqoshttp://www.intechopen.com/download/pdf/63466
Clinical Oncology10.1016/s0936-6555(05)80005-6199576359-365The search for optimal chemotherapy for advanced epithelial ovarian cancerK.J. Harrington, H.E. Lamberthttps://api.elsevier.com/content/article/PII:S0936655505800056?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0936655505800056?httpAccept=text/plain
Bangladesh Medical Research Council Bulletin10.3329/bmrcb.v48i2.623022023482154-159A Predictive Score after Neoadjuvant Chemotherapy for Optimal Cytoreduction at Interval Debulking Surgery in Advanced Epithelial Ovarian CancerPabina Afroz Parveen, Fawzia Hossain, Shah Mahfuzur Rahman, Rezwana Sharmin Lima, Anjuman Sultana, Nahida Sultanahttps://www.banglajol.info/index.php/BMRCB/article/download/62302/44650, https://www.banglajol.info/index.php/BMRCB/article/download/62302/44650
BMC Cancer10.1186/1471-2407-7-65200771Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancerRiccardo Samaritani, Giacomo Corrado, Enrico Vizza, Carlo Sbirolihttp://link.springer.com/content/pdf/10.1186/1471-2407-7-65.pdf, http://link.springer.com/article/10.1186/1471-2407-7-65/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-7-65, https://link.springer.com/content/pdf/10.1186/1471-2407-7-65.pdf
Medicine10.1097/md.0000000000029967202210132e29967Does protracted chemotherapy have an influence on the clinical outcomes in advanced epithelial ovarian cancer?Juhun Lee, Dae Gy Honghttps://journals.lww.com/10.1097/MD.0000000000029967
Gynecologic Oncology10.1016/j.ygyno.2012.01.00120121251279-281Re: “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial.” — Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.Luca Ansaloni, Pierandrea De Iaco, Luigi Frigeriohttps://api.elsevier.com/content/article/PII:S0090825812000054?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825812000054?httpAccept=text/plain
Gynecologic Oncology10.1016/j.ygyno.2013.05.02920131311241-245Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancerMaurie Markmanhttps://api.elsevier.com/content/article/PII:S0090825813007622?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0090825813007622?httpAccept=text/xml